- HPV Vaccine
- This vaccine was largely
developed as Dr. Rose's PhD thesis
in the Department of Microbiology and Immunology under Dr. Reichman's
mentorship. While most PhD theses sit on a shelf, Rose's led to the
patenting of the technology for HPV
vaccine development using virus-like particles.
Dr Rose's Faculty Page
Dr Reichman's Faculty Page
Ongoing Cancer Vaccine Research
Deans Newsletter About the Vaccine - Vaccines based on this research
- Gardasil
Cervarix - Meningitis Vaccine
- URMC
Faculty Member
David H. Smith developed the first vaccine for Haemophilus influenza
type b (Hib), the bacterium responsible for nearly all cases of
childhood meningitis. This is now administered to all newborns in the
U.S., and has reduced the incidence of bacterial meningitis by 98
percent. The Hib patent is also a major source of patent
revenue for the URMC, which ranks 6th in the national in patent revenue
(2003 data, Chronicle of Higher Education).
Recipient of the 1996 Lasker Award.
Founder of Praxis Biologics.
- Clinical & Translational Research
- The University of Rochester Medical Center is one of 12 Academic Health Centers participating in a new consortium that will ultimately enable researchers to provide new treatments more efficiently and quickly to patients.
-
For more information on this program:
- Program Home Page
- http://www.urmc.rochester.edu/pr/stsa/translational.cfm
- NIH description of the program
- http://www.ncrr.nih.gov/ncrrprog/roadmap/CTSA_9-2006.asp
- Dean Guzick's Announcement
- http://www.urmc.rochester.edu/smd/about/newsletterArchive/newsletter008042006.cfm